The PHRASE project celebrates a year of advancements in stroke care through AI-based personalized diagnosis and treatment
Personalised Health Cognitive Assistance for Rehabilitation System – The PHRASE project, funded by the European Innovation Council (EIC) Transition program, addresses the rapid increase in the number of stroke patients needing care and rehabilitation by offering AI-based personalized diagnostics, prognostics, and interventions.
According to the World Health Organization, stroke is the leading cause of disability and the second leading cause of death. The burden of cognitive and neuromotor impairment caused by stroke is on the rise, with over 80 million people living with its consequences worldwide. This rapid growth in the number of patients requiring care and rehabilitation necessitates an urgent, scientifically grounded, and scalable response.
The PHRASE project aims to meet this challenge by providing AI-based personalized interventions developed from multiscale computational models tailored to each patient, informing diagnosis, prognosis, and intervention planning. The three-year project is approaching its first year of execution in April 2023, when the first version of the Brain Health Pipeline will be delivered. This integration of technologies will encompass everything from data collection and processing to simulation and modeling, prediction of recovery, and intervention. Since the project's initiation in April 2022, consortium members have collaborated to define the scientific approach for intervention and diagnosis, establish patient data management guidelines, integrate technological components of the pipeline, and develop a clinical protocol for validation with patients. Stroke patient testing will commence in September 2023, coinciding with the 18-month mark of the project.
The integrated stroke rehabilitation pipeline of PHRASE will be validated with 1,000 patients across several European hospitals, aiming to shorten hospital stays, reduce personnel and transportation costs, and create a virtuous recovery cycle for patients.
Public Events
PHRASE will participate with Eodyne and EBRAINS in the HBP Summit 2023: Achievements and Future of Digital Brain Research, taking place in Marseille from March 28 to 31, 2023.
About the Consortium
The PHRASE consortium brings together a distinguished group of highly qualified experts: Charité University Medicine Berlin, EBRAINS AISBL, Saddle Point Science, and Radboud University, all with extensive experience in brain research, data science, cognitive sciences, and neurorehabilitation, as well as entrepreneurial profiles to ensure the success of this project.
About Eodyne Systems
Eodyne has a strong track record in developing scientifically-based neurorehabilitation solutions for the sector. Eodyne's expertise lies in developing and integrating advanced interactive systems that utilize technologies such as virtual and augmented reality, environmental and wearable sensors, artificial intelligence, and machine learning, focusing on maximizing clinical impact and user experience.
Background
The EIC Transition program finances innovation activities that go beyond experimental proof of concept in the lab and supports both:
- The maturation and validation of innovative technology from the lab to real-world application environments;
- The development of a business case and model for the future commercialization of the innovation.
Each project will receive a grant of up to €2.5 million (more in exceptional cases) and access to EIC Business Acceleration Services, which include advice, mentoring, and collaboration events. Projects can also apply for the Fast Track program to access the EIC Accelerator to support commercialization and expansion phases.
August 10, 2023, Barcelona
We have won the VBHC Community Award 2024 with the STRACK project!
The project was launched in May 2021 at the Hospital Universitari de Bellvitge, Hospital de Viladecans, and 18 primary care centers. The STRACK project has evolved continuity of care for nearly 400 patients by integrating comprehensive monitoring of cardiometabolic risk factors (heart failure, diabetes, atrial fibrillation, dyslipidemia, hypertension) into a personalized care plan for each patient.
In Spain, this project has set a precedent in the care of stroke patients, and we are pleased to see it awarded the community prize of the VBHC Prize 2024: an award recognizing inspiring initiatives focused on value-based health that have demonstrated positive health outcomes and efficient use of healthcare resources. This award is managed by the Value-Based Health Care Center Europe - News & Events and presented by Prof. Dr. Fred van Eenennaam and Honorary President Prof. Porter, who developed the VBHC concept about 20 years ago at Harvard Business School.
We are proud of our collaboration with Roche Diagnostics Spain and a multidisciplinary team of professionals from the Hospital Universitari de Bellvitge and Hospital de Viladecans in Barcelona.